1,834 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Van ECK Associates Corp

Van ECK Associates Corp bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,834 shares of the company's stock, valued at approximately $752,000.

Several other institutional investors have also recently added to or reduced their stakes in HCA. Capital World Investors raised its stake in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company's stock worth $931,342,000 after buying an additional 1,019,750 shares during the period. Lee Danner & Bass Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter worth $131,527,000. Darsana Capital Partners LP increased its stake in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock valued at $369,472,000 after purchasing an additional 400,000 shares in the last quarter. Swedbank AB acquired a new position in shares of HCA Healthcare during the first quarter valued at about $95,882,000. Finally, TD Asset Management Inc raised its holdings in shares of HCA Healthcare by 30.4% in the 1st quarter. TD Asset Management Inc now owns 721,318 shares of the company's stock worth $240,581,000 after acquiring an additional 168,093 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company's stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.70% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Morgan Stanley started coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 price objective for the company. Wolfe Research raised shares of HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Leerink Partners raised their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an "outperform" rating in a research report on Wednesday, July 24th. TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a research report on Monday, October 28th. Finally, Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research report on Monday, August 19th. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $385.00.

HCA Healthcare Stock Performance

Shares of HCA stock traded down $4.27 during trading on Tuesday, reaching $353.72. 307,703 shares of the company's stock traded hands, compared to its average volume of 1,174,091. The firm's 50-day moving average is $388.86 and its 200 day moving average is $356.86. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1 year low of $229.28 and a 1 year high of $417.14. The company has a market capitalization of $89.60 billion, a P/E ratio of 15.87, a PEG ratio of 1.36 and a beta of 1.68.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. HCA Healthcare's dividend payout ratio (DPR) is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.